CT分级下清胰汤联合激素治疗急性胰腺炎疗效观察  

Clinical Observation of Qingyi Tang Combined with Hormone for Acute Pancreatitis under CT Classification

作　　者：金京 毛英明 

机构地区：[1]宁波市鄞州第二医院放射科,浙江宁波315000

出　　处：《新中医》2016年第8期68-70,共3页New Chinese Medicine

摘　　要：目的:研究CT分级对清胰汤联合激素治疗急性胰腺炎(AP)疗效的评估价值。方法:收集本院消化内科54例AP患者,入院后在善得定治疗的基础上加用中药配方清胰汤(联合组),以同期单纯采用善得定治疗的30例AP患者作为对照组,观察2组治疗效果,并重点观察治疗组治疗前后CT影像Balthazar分级与疗效的相关性。结果:总有效率治疗组为94.44%,对照组为80.00%,2组比较,差异在有统计学意义(P<0.05)。不同CT分级的AP患者CT表现不同,CT能较好的观察AP的病变及转归程度;观察组治疗后患者CT分级轻度AP占92.59%(50/54),较治疗前轻度AP的62.93%(34/54)升高,差异有统计学意义(P<0.05)。结论:清胰汤联合激素可作为AP的有效治疗方法;CT扫描及分级能较好的观察反映AP病变和治疗病情转归程度,可为临床治疗疗效评估提供重要支持。Objective：To study the estimating value of CT classification on clinical effect of Qingyi tang combined with hormone for acute pancreatitis（AP）.Methods：Collected 54 cases of AP patients,Qingyi tang was added on base of conventional growth inhibiting hormone drugs Sandostatin after admission（denoted as the combination group）.And regarding 30 cases of AP patients that were treated merely with Sandostatin at the same term as the control group.Observed clinical effect of the two groups,especially CT image Balthazar classification and clinical effect correlation before and after treatment in the combination group.Results：The total effective rate in the combination group was 94.44%,and that in the control group was 80.00%,the difference being significant（P〈0.05）.CT expression of AP patients of different CT classification was different.CT can observe preferably AP pathology and outcome degree.After treatment,patients with slight AP in the combination group accounted for 92.59%（50/54）,and was higher than 62.93%（34/54） of slight AP before treatment,difference being significant（P〈0.05）.Conclusion：Qingyi tang combined with hormone for AP is effective.CT scan and classification can observe and react AP pathology and outcome degree preferably,which can provide important support for clinical effect evaluation during clinical treatment.

关 键 词：急性胰腺炎(AP) 清胰汤 激素 CT分级 疗效评估 

分 类 号：R657.51[医药卫生—外科学]